Literature DB >> 24635865

Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma.

Salma K Jabbour1, David Mulvihill2.   

Abstract

Adenocarcinomas of the ampulla of Vater and duodenum are more rare than pancreatic cancer and have a better prognosis. However, studies conducted on the management of these cancers, such as adjuvant chemotherapy and radiation therapy, are limited by small sample sizes and series that are retrospective. This review evaluates ampullary and duodenal adenocarcinomas with regard to incidence, anatomy, prognostic features, patterns of failure, and the available literature studying adjuvant therapy.
© 2013 Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24635865     DOI: 10.1016/j.semradonc.2013.11.001

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  14 in total

1.  Gastrointestinal Malignancy Presenting with a Virchow's Node in a Patient with Rothmund-Thomson Syndrome.

Authors:  Kara Nadeau; Michele Brule
Journal:  Case Rep Genet       Date:  2018-10-25

2.  Clinicopathologic and survival analysis of resected ampullary adenocarcinoma.

Authors:  Matthew P Doepker; Zachary J Thompson; Barbara A Centeno; Richard D Kim; Joyce Wong; Pamela J Hodul
Journal:  J Surg Oncol       Date:  2016-05-09       Impact factor: 3.454

3.  Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma.

Authors:  Pei-Ju Chuang; Hsiu-Po Wang; Yu-Jen Lin; Chieh-Chang Chen; Yu-Wen Tien; Min-Shu Hsieh; Shih-Hung Yang; Ruoh-Fang Yen; Chi-Lun Ko; Yen-Wen Wu; Mei-Fang Cheng
Journal:  Eur Radiol       Date:  2021-04-17       Impact factor: 5.315

4.  Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.

Authors:  Ibrahim Nassour; Alana Christie; Michael A Choti; John C Mansour; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; Matthew R Porembka; Xian-Jin Xie; Sam C Wang
Journal:  J Gastrointest Surg       Date:  2018-03-15       Impact factor: 3.452

5.  Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database.

Authors:  Yu Jin Lim; Kyubo Kim
Journal:  Int J Clin Oncol       Date:  2017-12-19       Impact factor: 3.402

6.  A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.

Authors:  Bobby V M Dasari; Keith J Roberts; James Hodson; Lewis Stevens; Andrew M Smith; Stefan G Hubscher; John Isaac; Paolo Muiesan; Robert P Sutcliffe; Ravi Marudanayagam; Darius F Mirza
Journal:  HPB (Oxford)       Date:  2016-02-24       Impact factor: 3.647

Review 7.  Primary small bowel adenomas and adenocarcinomas-recent advances.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  Virchows Arch       Date:  2018-07-11       Impact factor: 4.064

Review 8.  Brachytherapy in the treatment of bile duct cancer - a tough challenge.

Authors:  Janusz Skowronek; Grzegorz Zwierzchowski
Journal:  J Contemp Brachytherapy       Date:  2017-03-30

9.  Transduodenal ampullectomy provides a less invasive technique to cure early ampullary cancer.

Authors:  Yang Gao; Yayun Zhu; Xiuyan Huang; Hongcheng Wang; Xinyu Huang; Zhou Yuan
Journal:  BMC Surg       Date:  2016-06-01       Impact factor: 2.102

10.  Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.

Authors:  Michael Feretis; Tengyao Wang; Satheesh Iype; Adam Duckworth; Rebecca Brais; Bristi Basu; Neville V Jamieson; Emmanuel Huguet; Anita Balakrishnan; Asif Jah; Raaj K Praseedom; Simon J Harper; Siong-Seng Liau
Journal:  Pancreas       Date:  2017 Nov/Dec       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.